What Surgeons Should Know About Non–Vitamin K Oral Anticoagulants: A Review
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2018.0374
Abstract: Importance Non–vitamin K oral anticoagulants (NOACs) are increasingly prescribed for patients to treat or prevent arterial or venous thromboembolism. The following 4 NOAC agents are approved by the US Food and Drug Administration for clinical… read more here.
Keywords: vitamin oral; noac agents; non vitamin; oral anticoagulants ... See more keywords
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-021-02466-8
Abstract: There are now anticoagulant choices with proposed advantages of non-vitamin K oral anticoagulants (NOACs) over warfarin being less routine monitoring and less drug interactions. Interacting medication can impact the efficacy and safety of anticoagulant therapy… read more here.
Keywords: vitamin oral; non vitamin; drug interactions; warfarin ... See more keywords
Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1515913
Abstract: ABSTRACT Introduction: In patients with atrial fibrillation (AF), oral anticoagulation with vitamin K antagonists (VKA) (warfarin, phenprocoumon) is effective both for primary and secondary stroke prevention with a 60–70% relative reduction in stroke risk compared… read more here.
Keywords: vitamin oral; non vitamin; oral anticoagulants; prevention ... See more keywords
The use of non‐vitamin K oral anticoagulants in dialysis patients—A systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in Dialysis"
DOI: 10.1111/sdi.13098
Abstract: Non‐vitamin K oral anticoagulants (NOACs) are used for prevention of thromboembolic events, but their use in dialysis patients is debatable. This study investigated the available evidence for the use of NOACs in dialysis patients. Online… read more here.
Keywords: dialysis patients; non vitamin; dialysis; vitamin oral ... See more keywords
Haemorrhagic complications following cataract and vitreoretinal surgery with sub-Tenon’s block in patients receiving non–vitamin K oral anticoagulant agents: A prospective audit
Sign Up to like & getrecommendations! Published in 2022 at "Anaesthesia and Intensive Care"
DOI: 10.1177/0310057x211057136
Abstract: There is a lack of data to support either continuation or interruption of non–vitamin K oral anticoagulants for cataract and vitreoretinal surgery. A prospective audit was undertaken of 291 patients undergoing cataract surgery or vitreoretinal… read more here.
Keywords: sub tenon; non vitamin; vitamin oral; cataract vitreoretinal ... See more keywords
Protocol for the Vitamin D Oral Replacement in Asthma (VDORA) study.
Sign Up to like & getrecommendations! Published in 2022 at "Contemporary clinical trials"
DOI: 10.2139/ssrn.4068172
Abstract: Obesity and asthma are epidemic in the United States and obesity is an independent risk factor for asthma. Low vitamin D levels (i.e. serum 25-hydroxyvitamin D) have been reported in patients with reduced lung function,… read more here.
Keywords: protocol vitamin; asthma; vitamin; vitamin oral ... See more keywords
Non-vitamin K Oral Anticoagulants and Anti-seizure Medications: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2020.588053
Abstract: Purpose: Concerns of drug–drug interactions (DDIs) between anti-seizure medications (ASMs) and non-vitamin K oral anticoagulants (NOACs) have emerged in recent case reports and guidelines. Theoretically, the induction of hepatic cytochrome P450 3A4 (CYP3A4) enzyme and… read more here.
Keywords: vitamin oral; ddis; non vitamin; seizure medications ... See more keywords
Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.755009
Abstract: Objective: We aimed to compare non-vitamin K oral anticoagulants (NOACs) with a traditional antithrombotic such as vitamin K antagonist (VKA) and antiplatelet agents in patients after transcatheter aortic valve replacement (TAVR). Methods: We conducted a… read more here.
Keywords: aortic valve; non vitamin; valve replacement; vitamin oral ... See more keywords
Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.819878
Abstract: Major bleeding risks associated with non-vitamin K oral anticoagulants (NOACs) used with and without concurrent antipsychotics in patients with non-valvular atrial fibrillation (AF) were assessed. A total of 98,863 patients with non-valvular AF receiving at… read more here.
Keywords: major bleeding; non vitamin; vitamin oral; oral anticoagulants ... See more keywords
Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of stroke"
DOI: 10.5853/jos.2022.03552
Abstract: Atrial fibrillation (AF) is a leading cause of cardioembolic stroke, which is often fatal or disabling. Prevention of stroke is crucial in AF management, and anticoagulation with non-vitamin K oral anticoagulants (NOACs) is the mainstay… read more here.
Keywords: prevention; non vitamin; vitamin oral; atrial fibrillation ... See more keywords